These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19822830)

  • 21. Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfil guideline recommended targets? A report from the EUROASPIRE III cross-sectional study.
    Gyberg V; Kotseva K; Dallongeville J; Backer GD; Mellbin L; Rydén L; Wood D; Bacquer DD;
    Eur J Prev Cardiol; 2015 Jun; 22(6):753-61. PubMed ID: 24691153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescribing diabetes medication for cardiovascular risk reduction in patients admitted with acute coronary syndromes: a survey of cardiologists' attitudes and practice.
    Slater TA; Drozd M; Palin V; Bowles C; Waduud MA; Khatib R; Ajjan RA; Wheatcroft SB
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(3):194-196. PubMed ID: 31702003
    [No Abstract]   [Full Text] [Related]  

  • 23. Prescriber Continuity and Disease Control of Older Adults.
    Maciejewski ML; Hammill BG; Bayliss EA; Ding L; Voils CI; Curtis LH; Wang V
    Med Care; 2017 Apr; 55(4):405-410. PubMed ID: 27755393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The right drug at the right dose (how doctors decide what to prescribe).
    Marino MT
    Diabetes Self Manag; 2011; 28(2):8, 10-2, 14. PubMed ID: 21510246
    [No Abstract]   [Full Text] [Related]  

  • 25. Antihypertensive medication prescribing in 27,822 elderly Canadians with diabetes over the past decade.
    McAlister FA; Campbell NR; Duong-Hua M; Chen Z; Tu K
    Diabetes Care; 2006 Apr; 29(4):836-41. PubMed ID: 16567824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statins and diabetes.
    Hitman GA
    Diabet Med; 2014 Jun; 31(6):639. PubMed ID: 24835891
    [No Abstract]   [Full Text] [Related]  

  • 27. Risk Factor Control in Stroke Survivors with Diagnosed and Undiagnosed Diabetes: A Ghanaian Registry Analysis.
    Sarfo FS; Akassi J; Agyei M; Kontoh S; Ovbiagele B
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105304. PubMed ID: 32992189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recent trends in diabetic complications in Japan].
    Sone H; Saito Y; Yoshimura Y; Ishibashi S; Ito H; Yamashita H; Yamazaki Y; Katayama S; Ohashi Y; Akanuma Y; Yamada N
    Nihon Naika Gakkai Zasshi; 2004 Nov; 93(11):2427-34. PubMed ID: 15624483
    [No Abstract]   [Full Text] [Related]  

  • 29. Which person with diabetes should receive cardioprotective glucose-lowering medicines?
    Bloomgarden ZT
    J Diabetes; 2020 May; 12(5):352-353. PubMed ID: 32119186
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diabetic neuropathy: new therapeutic options?].
    Haslbeck M
    MMW Fortschr Med; 2006 Nov; 148(44):41-4. PubMed ID: 17619441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of antihypertensive therapy among patients with diabetes.
    Johnson ML; Singh H
    J Gen Intern Med; 2005 Sep; 20(9):842-6. PubMed ID: 16117753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.
    McWilliams JM; Najafzadeh M; Shrank WH; Polinski JM
    JAMA Cardiol; 2017 Sep; 2(9):1019-1023. PubMed ID: 28700790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health care delivery in type 2 diabetes. A survey in an Italian primary care practice.
    Modesti A; Bartaloni R; Bellagamba F; Caglieri R; Cenori K; Ciampalini G; Costagli A; Galloni V; Del Papa C; Modesti L; Dell'Omo G; Pedrinelli R
    Prim Care Diabetes; 2015 Feb; 9(1):9-14. PubMed ID: 24908631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Change in cardiovascular risk factors in relation to diabetes status: the Tromso Study.
    Joseph J; Svartberg J; Njølstad I; Schirmer H
    Eur J Prev Cardiol; 2012 Jun; 19(3):551-7. PubMed ID: 21505026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mortality associated with less intense risk-factor control among adults with diabetes in the United States.
    Saydah SH; Gregg EW; Kahn HS; Ali MK
    Prim Care Diabetes; 2018 Feb; 12(1):3-12. PubMed ID: 28797537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variation in the net benefit of aggressive cardiovascular risk factor control across the US population of patients with diabetes mellitus.
    Timbie JW; Hayward RA; Vijan S
    Arch Intern Med; 2010 Jun; 170(12):1037-44. PubMed ID: 20585069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Importance of glycemic control.
    Shahady EJ
    J Fam Pract; 2011 Sep; 60(9 Suppl):S4-6. PubMed ID: 21912776
    [No Abstract]   [Full Text] [Related]  

  • 38. Quality of Care of the Initial Patient Cohort of the Diabetes Collaborative Registry
    Arnold SV; Goyal A; Inzucchi SE; McGuire DK; Tang F; Mehta SN; Sperling LS; Maddox TM; Einhorn D; Wong ND; Hammar N; Fenici P; Khunti K; Lam CSP; Kosiborod M
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensive glycemic control in younger and older U.S. adults with type 2 diabetes.
    Casagrande S; Cowie CC; Fradkin JE
    J Diabetes Complications; 2017 Aug; 31(8):1299-1304. PubMed ID: 28571934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of cardiovascular events in diabetes.
    Sigal R; Malcolm J; Arnaout A
    Clin Evid; 2006 Jun; (15):623-45. PubMed ID: 16973029
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.